1,316 reports of this reaction
3.5% of all AXITINIB reports
#5 most reported adverse reaction
HYPERTENSION is the #5 most commonly reported adverse reaction for AXITINIB, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 1,316 FDA adverse event reports linking AXITINIB to HYPERTENSION. This represents approximately 3.5% of all 37,114 adverse event reports for this drug.
Patients taking AXITINIB who experience hypertension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPERTENSION is moderately reported among AXITINIB users, representing a notable but not dominant share of adverse events.
In addition to hypertension, the following adverse reactions have been reported for AXITINIB:
The following drugs have also been linked to hypertension in FDA adverse event reports:
HYPERTENSION has been reported as an adverse event in 1,316 FDA reports for AXITINIB. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPERTENSION accounts for approximately 3.5% of all adverse event reports for AXITINIB, making it a notable side effect.
If you experience hypertension while taking AXITINIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.